| Action | Amend regulation to require each family day home provider or other caregiver to be trained in epinephrine administration; notification requirements to parents required |
| Stage | Fast-Track |
| Comment Period | Ended on 12/17/2025 |
 |
The high cost of EpiPens, along with their relatively short shelf lives and high replacement costs, creates a significant and ongoing financial burden for organizations, especially small ones with limited budgets. Funds for buying and frequently replacing expired devices might be diverted from other critical needs. It would also force providers to regularly bear the cost of replacing the medicine.